Xiaorong Zhou

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 18

Top Topics

Natural Killer Cells

Top Venues

Molecules (Basel, Switzerland)

Journal of oncology

Journal of inflammation research

This page only lists publications with an associated author ORCID identifier.

Publications

Yunhan Wang, Boyu Zhang, Zongying Zhang, Jia Ge, Lin Xu, Jiawei Mao, Xiaorong Zhou, Liming Mao, Qiuyun Xu, Mengmeng Sang
Predicting Prognosis and Immunotherapy Response in Multiple Cancers Based on the Association of PANoptosis-Related Genes with Tumor Heterogeneity. Genes 14 (11) (2023)
Xin Yu, Lijun Xu, Yongqiang Zhou, Xiaorong Zhou, Lei Yang, Yan Zhou
NUP62CL as an Immunological and Prognostic Biomarker of Oral Squamous Cell Carcinoma. Journal of inflammation research 16 (2023)
Zongying Zhang, Anqi Wang, Yunhan Wang, Weichen Sun, Xiaorong Zhou, Qiuyun Xu, Liming Mao, Jie Zhang
Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators. Molecules (Basel, Switzerland) 28 (8) (2023)
Sijun Chen, Feijing Wu, Jiaxuan Zhang, Jianwei Zhu, Xiaorong Zhou, Xiaofei Zhi
ADRB2 Regulates the Proliferation and Metastasis of Gastrointestinal Stromal Tumor Cells by Enhancing the ETV1-c-KIT Signaling. Journal of oncology 2023 (2023)
Zongying Zhang, Anqi Wang, Yunhan Wang, Weichen Sun, Xiaorong Zhou, Qiuyun Xu, Liming Mao, Jie Zhang
Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators. Molecules (Basel, Switzerland) 28 (8) (2023)
Xin Yu, Simin Yang, Wenqian Xia, Xiaorong Zhou, Meiqin Gao, Hui Shi, Yan Zhou
Identification of a Novel Variant of PDGFC Associated with Nonsyndromic Cleft Lip and Palate in a Chinese Family. International journal of genomics 2023 (2023)
Zongying Zhang, Yunhan Wang, Qiuyun Xu, Xiaorong Zhou, Yong Ling, Jie Zhang, Liming Mao
Methyl Canthin-6-one-2-carboxylate Restrains the Migration/Invasion Properties of Fibroblast-like Synoviocytes by Suppressing the Hippo/YAP Signaling Pathway. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)
Yunhan Wang, Yu Zhao, Zongying Zhang, Jie Zhang, Qiuyun Xu, Xiaorong Zhou, Liming Mao
High Expression of CDCA7 in the Prognosis of Glioma and Its Relationship with Ferroptosis and Immunity. Genes 14 (7) (2023)
Sijun Chen, Feijing Wu, Jiaxuan Zhang, Jianwei Zhu, Xiaorong Zhou, Xiaofei Zhi
ADRB2 Regulates the Proliferation and Metastasis of Gastrointestinal Stromal Tumor Cells by Enhancing the ETV1-c-KIT Signaling. Journal of oncology 2023 (2023)
Zongying Zhang, Anqi Wang, Yunhan Wang, Weichen Sun, Xiaorong Zhou, Qiuyun Xu, Liming Mao, Jie Zhang
Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators. Molecules (Basel, Switzerland) 28 (8) (2023)
Zongying Zhang, Anqi Wang, Yunhan Wang, Weichen Sun, Xiaorong Zhou, Qiuyun Xu, Liming Mao, Jie Zhang
Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators. Molecules (Basel, Switzerland) 28 (8) (2023)
Yu Zhao, Yuejiao Cao, Yiqi Chen, Lei Wu, Hua Hang, Chenxia Jiang, Xiaorong Zhou
B2M gene expression shapes the immune landscape of lung adenocarcinoma and determines the response to immunotherapy. Immunology 164 (3) (2021)
Jie Zhang, Qiuyun Xu, Weichen Sun, Xiaorong Zhou, Da Fu, Liming Mao
New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease. Journal of inflammation research 14 (2021)
Ying Liu, Lei Wu, Hong Lu, En Wu, Jun Ni, Xiaorong Zhou
Enhancing the Therapeutic Efficacy of KRASG12C Inhibitors in Lung Adenocarcinoma Cell Models by Cotargeting the MAPK Pathway or HSP90. Journal of oncology 2021 (2021)
Qiuyun Xu, Xiaorong Zhou, Warren Strober, Liming Mao
Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease. Molecules (Basel, Switzerland) 26 (6) (2021)
Mangze Hu, Yu Zhao, Yuejiao Cao, Qianru Tang, Ziqin Feng, Jun Ni, Xiaorong Zhou
DRP1 promotes lactate utilization in KRAS-mutant non-small-cell lung cancer cells. Cancer science 111 (10) (2020)
Xiaoling Ding, Jie Zhang, Ziqin Feng, Qianru Tang, Xiaorong Zhou
MiR-137-3p Inhibits Colorectal Cancer Cell Migration by Regulating a KDM1A-Dependent Epithelial-Mesenchymal Transition. Digestive diseases and sciences 66 (7) (2020)
Yu Zhao, Xiaorong Zhou
Engineering chimeric antigen receptor-natural killer cells for cancer immunotherapy. Immunotherapy 12 (9) (2020)